KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Christo

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Rating) insider Christopher Yea sold 2,604 shares of KalVista Pharmaceuticals stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $10.14, for a total value of $26,404.56. Following the sale, the insider now directly owns 37,310 shares of the company’s stock, valued […]

Related Keywords

, Tang Capital Management , Kalvista Pharmaceuticals Inc , Needham Company , Quarter For Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Price Performance , Cantor Fitzgerald , Vr Adviser , Nasdaq , Boxer Capital , Kalvista Pharmaceuticals , Jefferies Financial Group Inc , Frazier Life Sciences Management , Institutional Trading Of Kalvista Pharmaceuticals , News Ratings For Kalvista Pharmaceuticals Daily , Securities Exchange Commission , Get Rating , Christopher Yea , Exchange Commission , Vista Pharmaceuticals , Capital Management , Jefferies Financial Group , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Kalv , Medical , Insider Trading , Nsider Trades , Stocks ,